Contineum Therapeutics, Inc. (CTNM) vs Bright Minds Biosciences Inc. (DRUG)
A side-by-side comparison of Contineum Therapeutics, Inc. and Bright Minds Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTNM
Contineum Therapeutics, Inc.
$12.58HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
DRUG
Bright Minds Biosciences Inc.
$48.54HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — CTNM vs DRUG
growth of $100 · dividends reinvested · last 2yCTNM -17.4% (-9.1%/yr)DRUG +3730.0% (+518.9%/yr)DRUG compounded faster over this window
Log scale — wide-divergence pair
CTNM DRUG
CTNM vs DRUG: by the numbers
- •DRUG is the larger company ($475M vs $473M market cap).
Metrics side by side
Valuation
| Metric | CTNM | DRUG |
|---|---|---|
| P/B ratio | 1.97 | 2.19 |
Profitability
| Metric | CTNM | DRUG |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -24.02% | -8.21% |
| ROIC | -27.22% | -13.15% |
Growth (annualized)
| Metric | CTNM | DRUG |
|---|---|---|
| Total return CAGR (5Y) | N/A | 6.76% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.